Return on Investments: An indicator of how profitable a company is relative to its assets invested by shareholders and long-term bond holders. Calculated by dividing a company's operating earnings by its long-term debt and shareholders equity. Calculated as: Income from Continuing Operations / (Total Long-Term Debt + Shareholders Equity)
Compass Therapeutics, Inc. (CMPX) had Return on Investments of -15.15% for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
$-25.15M |
|
-- |
|
-- |
|
$26.98M |
|
$-26.98M |
|
$1.82M |
|
$-25.15M |
|
$-25.15M |
|
$-25.15M |
|
$-25.15M |
|
$-25.15M |
|
$-25.15M |
|
$-26.98M |
|
$-26.80M |
|
186.80M |
|
186.80M |
|
$-0.13 |
|
$-0.13 |
|
| Balance Sheet Financials | |
$180.89M |
|
$0.32M |
|
$9.28M |
|
$190.17M |
|
$16.13M |
|
-- |
|
$8.00M |
|
$24.12M |
|
$166.05M |
|
$166.05M |
|
$166.05M |
|
180.09M |
|
| Cash Flow Statement Financials | |
$-32.01M |
|
$33.45M |
|
$3.37M |
|
$31.21M |
|
$36.02M |
|
$4.81M |
|
$9.89M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
11.22 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-32.27M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-15.15% |
|
-15.15% |
|
-13.23% |
|
|
Return on Investments |
-15.15% |
$0.92 |
|
$-0.17 |
|
$-0.17 |
|